Reaction Details |
| Report a problem with these data |
Target | Aurora kinase B |
---|
Ligand | BDBM50446457 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1287773 (CHEMBL3111605) |
---|
IC50 | >100000±n/a nM |
---|
Citation | Naud, S; Westwood, IM; Faisal, A; Sheldrake, P; Bavetsias, V; Atrash, B; Cheung, KM; Liu, M; Hayes, A; Schmitt, J; Wood, A; Choi, V; Boxall, K; Mak, G; Gurden, M; Valenti, M; de Haven Brandon, A; Henley, A; Baker, R; McAndrew, C; Matijssen, B; Burke, R; Hoelder, S; Eccles, SA; Raynaud, FI; Linardopoulos, S; van Montfort, RL; Blagg, J Structure-based design of orally bioavailable 1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1). J Med Chem56:10045-65 (2013) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Aurora kinase B |
---|
Name: | Aurora kinase B |
Synonyms: | AIK2 | AIM-1 | AIM1 | AIRK2 | ARK2 | AURKB | AURKB_HUMAN | Aurora B kinase (aurB) | Aurora B-INCENP | Aurora kinase 2 | Aurora kinase B (AURKB) | Aurora-related kinase 2 | STK-1 | STK1 | STK12 | STK5 | Serine/threonine-protein kinase aurora B |
Type: | Protein |
Mol. Mass.: | 39327.72 |
Organism: | Homo sapiens (Human) |
Description: | Q96GD4 |
Residue: | 344 |
Sequence: | MAQKENSYPWPYGRQTAPSGLSTLPQRVLRKEPVTPSALVLMSRSNVQPTAAPGQKVMEN
SSGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEH
QLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATI
MEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYL
PPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPMGA
QDLISKLLRHNPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA
|
|
|
BDBM50446457 |
---|
n/a |
---|
Name | BDBM50446457 |
Synonyms: | CHEMBL3109966 |
Type | Small organic molecule |
Emp. Form. | C17H14ClN5 |
Mol. Mass. | 323.78 |
SMILES | Cn1cc(cn1)-c1cc2cnc(Nc3ccccc3Cl)cc2[nH]1 |
Structure |
|